West Pharmaceutical Services, Inc. (WST) Stock Overview
Explore West Pharmaceutical Services, Inc.’s financial performance, market position, analyst ratings, and future outlook.
West Pharmaceutical Services, Inc. (WST)
Key Financials
Key Financials
Market Cap
29.3B
P/E Ratio
51.07
EPS (TTM)
$8.50
ROE
0.19%
WST Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of West Pharmaceutical Services, Inc. (NYSE: WST) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, West Pharmaceutical Services, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of WST on the NYSE shows an RSI of 76.15, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $281.77 for the NYSE listing.
Key metrics behind West Pharmaceutical Services, Inc.'s NYSE-traded stock include a P/E ratio of 51.07 and a market capitalization of 29.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of WST on the NYSE.